Perpetual Medicines Completes $8 Million Seed Round To Advance Integrated Computational Design-Synthesis Platform For Peptide Drug Discovery
Amount Raised
$8 Million
Round Type
Seed
ShanghaiBiotechnologyInvestors
Description
Perpetual Medicines today announced it has closed an $8 million seed financing to advance its integrated computational design and synthesis platform for peptide drug discovery. The financing round was led by Chengwei Capital.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Perpetual Medicines that raised within 45 days of this round, from Fundz verified event records.
- Mindera Health raised $14M on January 12, 2024.
- Avant Sciences raised $175K on January 12, 2024.
- Streamex Corp. raised $1.5M (Seed) on January 12, 2024.
- Motif Neurotech raised $15M on January 12, 2024.
- Reunion Neuroscience Management raised $120M on January 12, 2024.
- Mitosense raised $1.9M (Seed) on January 11, 2024.
Who to call at Perpetual Medicines, and when
A new round usually means Perpetual Medicines is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Perpetual Medicines raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Perpetual Medicines, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Perpetual Medicines. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Perpetual Medicines raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Perpetual Medicines raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.